176 related articles for article (PubMed ID: 23347903)
61. Classic hairy cell leukemia with an aggressive presentation.
Fugere T; Harley S; Godbole A
Proc (Bayl Univ Med Cent); 2021; 34(6):721-723. PubMed ID: 34733001
[TBL] [Abstract][Full Text] [Related]
62. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.
Kreitman RJ; Arons E
Blood Rev; 2022 Jan; 51():100888. PubMed ID: 34535326
[TBL] [Abstract][Full Text] [Related]
63. Hairy Cell Leukemia Masquerading as CD5+ Lymphoproliferative Disease: The Importance of
Soong D; Kumar P; Jatwani K; Park J; Dogan A; Taylor J
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250418
[No Abstract] [Full Text] [Related]
64. Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.
Balakrishna J; Basumallik N; Matulonis R; Scott D; Salem D; Jasper G; Wiestner A; Stetler-Stevenson M; Marti G; Sun C; Yuan CM
Leuk Lymphoma; 2021 Aug; 62(8):1828-1839. PubMed ID: 33734005
[TBL] [Abstract][Full Text] [Related]
65. Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant.
Liu Q; Harris N; Epperla N; Andritsos LA
Onco Targets Ther; 2021; 14():1797-1805. PubMed ID: 33727830
[TBL] [Abstract][Full Text] [Related]
66. A Rare Case of Hairy Cell Leukemia with Unusual Loss of CD123 Associated with COVID-19 at the Time of Presentation.
Kohla S; Ibrahim FA; Aldapt MB; ELSabah H; Mohamed S; Youssef R
Case Rep Oncol; 2020; 13(3):1430-1440. PubMed ID: 33442367
[TBL] [Abstract][Full Text] [Related]
67. Role of Specific B-Cell Receptor Antigens in Lymphomagenesis.
Thurner L; Hartmann S; Neumann F; Hoth M; Stilgenbauer S; Küppers R; Preuss KD; Bewarder M
Front Oncol; 2020; 10():604685. PubMed ID: 33363034
[TBL] [Abstract][Full Text] [Related]
68. Development of Recombinant Immunotoxins for Hairy Cell Leukemia.
Kreitman RJ; Pastan I
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32756468
[TBL] [Abstract][Full Text] [Related]
69. Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features.
Obiorah IE; Francischetti IMB; Wang HW; Ahn IE; Wang W; Raffeld M; Kreitman RJ; Wiestner A; Calvo KR
Leuk Lymphoma; 2020 Dec; 61(13):3177-3187. PubMed ID: 32755330
[TBL] [Abstract][Full Text] [Related]
70. Hairy Cell Leukaemia.
Cross M; Dearden C
Curr Oncol Rep; 2020 Apr; 22(5):42. PubMed ID: 32297104
[TBL] [Abstract][Full Text] [Related]
71. Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas.
Bailey NG; Elenitoba-Johnson KSJ
Cold Spring Harb Perspect Med; 2020 Nov; 10(11):. PubMed ID: 31932467
[TBL] [Abstract][Full Text] [Related]
72. Usefulness of Dual Immunohistochemistry Staining in Detection of Hairy Cell Leukemia in Bone Marrow.
Gupta GK; Sun X; Yuan CM; Stetler-Stevenson M; Kreitman RJ; Maric I
Am J Clin Pathol; 2020 Feb; 153(3):322-327. PubMed ID: 31665200
[TBL] [Abstract][Full Text] [Related]
73. CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies.
Testa U; Pelosi E; Castelli G
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31547472
[TBL] [Abstract][Full Text] [Related]
74. "Hairiness" is a Facsimile of Reorganized Cytoskeletons: A Cytopathic Effect of
Lee WY
Yonsei Med J; 2019 Oct; 60(10):890-897. PubMed ID: 31538423
[TBL] [Abstract][Full Text] [Related]
75. Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations.
Nobre CF; Newman MJ; DeLisa A; Newman P
Cancer Chemother Pharmacol; 2019 Aug; 84(2):255-263. PubMed ID: 31134324
[TBL] [Abstract][Full Text] [Related]
76. Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.
Salem DA; Scott D; McCoy CS; Liewehr DJ; Venzon DJ; Arons E; Kreitman RJ; Stetler-Stevenson M; Yuan CM
Cytometry B Clin Cytom; 2019 Jul; 96(4):275-282. PubMed ID: 31077558
[TBL] [Abstract][Full Text] [Related]
77. Hairy cell leukemia: present and future directions.
Kreitman RJ
Leuk Lymphoma; 2019 Dec; 60(12):2869-2879. PubMed ID: 31068044
[TBL] [Abstract][Full Text] [Related]
78. The expansion of targetable biomarkers for CAR T cell therapy.
Townsend MH; Shrestha G; Robison RA; O'Neill KL
J Exp Clin Cancer Res; 2018 Jul; 37(1):163. PubMed ID: 30031396
[TBL] [Abstract][Full Text] [Related]
79. Update on hairy cell leukemia.
Kreitman RJ; Arons E
Clin Adv Hematol Oncol; 2018 Mar; 16(3):205-215. PubMed ID: 29742076
[TBL] [Abstract][Full Text] [Related]
80. [Cladribine in treatment of 5 patients with hairy cell leukemia].
Liu ZY; Chen Y; Chen YB; Yan ZY; Wang Y; Li JM; Sun HM; Zhang SJ
Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):236-238. PubMed ID: 29562470
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
